315 Results for "

PBMC

" in MedChemExpress (MCE) Product Catalog:
Products (315)

315 Results for "PBMC" in MCE Product Catalog:

177
177 Publications Verification
Cat. No.: HY-13205
CAS No.: 273404-37-8
Purity:  99.99%
Synonyms: VX-765
Target:  

Caspase

Research Areas:  

Inflammation/Immunology

Belnacasan (VX-765) is an orally bioactive proagent of VRT-043198, which is a potent and selective inhibitor of IL-converting enzyme (ICE)/caspase-1 with Kis of 0.8 nM and less than 0.6 nM for caspase-1 and caspase-4, respectively. Belnacasan (VX-765) inhibits the release of LPS-induced IL-1β and IL-18 by human PBMCs with an IC50 of ~0.7 μM .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-14644
CAS No.: 541550-19-0
Purity:  99.80%
Synonyms: STA 5326; LAM-002A free base; AIT-101
Research Areas:  

Inflammation/Immunology Cancer

Apilimod (STA 5326) is a potent IL-12/IL-23 inhibitor, and strongly inhibits IL-12 with IC50s of 1 nM and 2 nM, in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively . Apilimod is a potent and highly selective PIKfyve inhibitor.
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-14644A
CAS No.: 870087-36-8
Purity:  99.83%
Synonyms: STA 5326 mesylate; LAM-002A; AIT-101 mesylate
Research Areas:  

Inflammation/Immunology Cancer

Apilimod (STA 5326) mesylate is a potent IL-12/IL-23 inhibitor, and strongly inhibits IL-12 with IC50s of 1 nM and 2 nM, in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively . Apilimod is a potent and highly selective PIKfyve inhibitor.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-129047
CAS No.: 9002-07-7
Purity:  91.00%
Trypsin is a serine protease enzyme, and hydrolyzes proteins at the carboxyl side of the Lysine or Arginine. Trypsin activates PAR2 and PAR4. Trypsin induces cell-to-cell membrane fusion in PDCoV infection by the interaction of S glycoprotein of PDCoV and pAPN. Trypsin also promotes cell proliferation and differentiation. Trypsin can be used in the research of wound healing and neurogenic inflammation .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-149179
CAS No.: 1404-26-8
Purity:  ≥91.0%
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Polymyxin B is an antibiotic. Polymyxin B inhibits Gram-negative infections by binding to the LPS of the bacterial wall with high affinity. Polymyxin B neutralizes the effect of endotoxin. Polymyxin B induces bacterial death by increasing its permeability. Polymyxin B is used in endotoxemia research .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-19744
CAS No.: 2437475-16-4
Target:  

MyD88

Research Areas:  

Inflammation/Immunology

T6167923 is a selective inhibitor of MyD88-dependent signaling pathways. T6167923 directly binds to Toll/IL1 receptor (TIR) domain of MyD88 and disrupts MyD88 homodimeric formation. T6167923 inhibits NF-κB driven Staphylococcus enterotoxin AP (SEAP) activity, and improves anti-inflammatory activity with IC50s of 2.7 μM, 2.9 μM, 2.66 μM and 2.66 μM for IFN-γ, IL-1β, IL-6 and TNF-α, respectively .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B1078
CAS No.: 27164-46-1
Synonyms: Cephazolin sodium
Cefazolin sodium is a first-generation cephalosporin antibiotic and can be used in varieties of bacterial infections research . Cefazolin sodium has anti-inflammatory effect and can attenuate post-operative cognitive dysfunction (POCD) .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B1892
CAS No.: 25953-19-9
Synonyms: Cephazolin
Cefazolin (Cephazolin) is a first-generation cephalosporin antibiotic and can be used in varieties of bacterial infections research . Cefazolin has anti-inflammatory effect and can attenuate post-operative cognitive dysfunction (POCD) .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12085
CAS No.: 608141-41-9
Purity:  99.91%
Synonyms: CC-10004
Apremilast (CC-10004) is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-17427
CAS No.: 143491-57-0
Synonyms: BW1592
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-50101
CAS No.: 558447-26-0
Synonyms: AMD-070; AMD-11070
Target:  

CXCR HIV

Research Areas:  

Infection Endocrinology Cancer

Mavorixafor (AMD-070) is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively. Mavorixafor can be used for the study of WHIM syndrome .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-50101A
CAS No.: 2309699-17-8
Synonyms: AMD-070 trihydrochloride; AMD-11070 trihydrochloride
Target:  

CXCR HIV

Research Areas:  

Infection Endocrinology Cancer

Mavorixafor trihydrochloride (AMD-070 trihydrochloride) is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively.Mavorixafor trihydrochloride can be used for the study of WHIM syndrome .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-50101C
CAS No.: 880549-30-4
Synonyms: AMD-070 hydrochloride; AMD-11070 hydrochloride
Target:  

CXCR HIV

Research Areas:  

Infection Cancer

Mavorixafor (AMD-070) hydrochloride is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding. Mavorixafor hydrochloride also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 nM and 9 nM, respectively. Mavorixafor hydrochloride can be used for the study of WHIM syndrome .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-B0689
CAS No.: 150378-17-9
Synonyms: MK-639 free base; L-735524 free base
Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CL pro inhibitor .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-B0689A
CAS No.: 157810-81-6
Synonyms: MK-639; L735524
Research Areas:  

Infection Cancer

Indinavir sulfate (MK-639) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir sulfate exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir sulfate is also a SARS-CoV 3CL pro inhibitor .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-19836
CAS No.: 1817626-54-2
Synonyms: PF-06650833
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

Zimlovisertib (PF-06650833) is a potent, selective and orally active inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4) with IC50s of 0.2 and 2.4 nM in the cell and PBMC assay, respectively. Zimlovisertib is used to treat diseases such as rheumatoid arthritis, lupus, and lymphomas .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-110133
CAS No.: 188791-09-5
Purity:  98.64%
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

JTE-607, a highly selective inflammatory cytokine synthesis inhibitor, protects from endotoxin shock in mice. JTE-607 inhibits inflammatory cytokine production, including TNF-α, IL-1β, IL-6, IL-8 and IL-10, from LPS-stimulated human PBMCs, with IC50s of 11, 5.9, 8.8, 7.3 and 9.1 nM, respectively . Cleavage and Polyadenylation Specificity Factor 3 (CPSF3) is the target of JTE-607 .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-120072
CAS No.: 1352879-65-2
Purity:  98.89%
Synonyms: PF-74
Target:  

HIV

Research Areas:  

Infection

PF-3450074 (PF-74) is a specifical inhibitor of HIV-1 capsid protein (CA) and displays a broad-spectrum inhibition of HIV isolates with submicromolar potency (EC50=8-640 nM). PF-3450074 (PF-74) acts at an early stage of HIV-1 infection, inhibits viral replication by directly competing with the binding of CPSF6 and NUP153, and blocks the uncoating, assembly, and the reverse transcription steps of the viral life cycle . CPSF6: nuclear host factors cleavage and polyadenylation specific factor 6; NUP153: nucleoporin 153.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114419
CAS No.: 1629677-75-3
Purity:  99.89%
Synonyms: KZR-616
Target:  

Proteasome

Research Areas:  

Inflammation/Immunology

Zetomipzomib (KZR-616), a first-in-class inhibitor of the immunoproteasome, selectively targets the LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP7/mLMP7) subunits of the immunoproteasome. Zetomipzomib has the potential for the research of multiple autoimmune diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114419A
CAS No.: 2170983-62-5
Purity:  99.84%
Synonyms: KZR-616 maleate
Target:  

Proteasome

Research Areas:  

Inflammation/Immunology

Zetomipzomib (KZR-616) maleate, a first-in-class immunoproteasome inhibitor, selectively targets the LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP2/mLMP2) subunits of the immunoproteasome. Zetomipzomib maleate has the potential for the research of multiple autoimmune diseases .
loading...
    loading...